Nascent Biotech, Inc. (OTCMKTS:NBIO – Get Free Report) was the recipient of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 3,200 shares, a decrease of 20.0% from the August 15th total of 4,000 shares. Based on an average trading volume of 226,700 shares, the short-interest ratio is presently 0.0 days.
Nascent Biotech Price Performance
Nascent Biotech stock traded up $0.00 during trading hours on Tuesday, hitting $0.05. 226,000 shares of the stock were exchanged, compared to its average volume of 101,705. The business’s 50-day moving average is $0.05 and its two-hundred day moving average is $0.09. Nascent Biotech has a 12 month low of $0.03 and a 12 month high of $0.28.
Nascent Biotech Company Profile
See Also
- Five stocks we like better than Nascent Biotech
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What is MarketRankā¢? How to Use it
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
- What is a Death Cross in Stocks?
- What Buybacks and Lower Rates Could Mean for Restaurant Brands
Receive News & Ratings for Nascent Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nascent Biotech and related companies with MarketBeat.com's FREE daily email newsletter.